• 1
    Grossi, P. A. 2012. Update in HIV infection in organ transplantation. Curr. Opin. Organ Transplant. 17:586593.
  • 2
    Bhagan, S., P. I. Sweny, and G. Brook. 2006. Guidelines for kidney transplantation in patients with HIV disease. HIV Med. 7:133139.
  • 3
    Muller, E., D. Kahn, and M. Mendelson. 2012. Renal transplantation between HIV-positive donors and recipients. N. Engl. J. Med. 362:23362337.
  • 4
    Stock, P. G., B. Barin, B. Murphy, D. Hanto, J. M. Diego, J. Light, et al. 2010. Outcomes in kidney transplantation in HIV infected recipients. N. Engl. J. Med. 363:20042014.
  • 5
    Siewe, B., and B. Landay. 2012. Effector and regulatory roles for B cells in HIV infection? Autoimmunity 45:348352.
  • 6
    Fillatreau, S., D. Gray, and S. M. Anderton. 2008. Not always the bad guys: B cells as regulators of autoimmune pathology. Nat. Rev. Immunol. 8:391397.
  • 7
    Fillatreau, S., C. H. Sweenie, M. J. McGreachy, D. Gray, and S. M. Anderton. 2002. B cells mediate autoimmunity by provision of IL-10. Nat. Immunol. 3:944950.
  • 8
    Iwata, Y., T. Matsushita, M. Horikawa, D. J. Dilillo, K. Yanaba, G. M. Venturi, et al. 2011. Characterization of a rare IL-10 competent B cell subset in humans that parallels mouse regulatory B cells. Blood 117:530541.
  • 9
    Blair, P. A., L. Y. Norena, F. Flores-Borja, D. J. Rawlings, D. A. Isenberg, M. R. Ehrenstein, et al. 2010. CD19(+)-CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity 32:129140.
  • 10
    Furuzawa-Carballeda, J., G. Lima, P. Simancas, D. Ramos-Bello, M. Simancas, I. C. Bostock, et al. 2012. Peripheral regulatory cells immunophenotyping in kidney transplant recipients with different clinical profiles: a cross-sectional study. J. Transplant. 2012:256960.
  • 11
    Furuzawa-Carballeda, J., G. Lima, J. Alberú, D. Palafox, N. Uribe-Uribe, L. E. Morales-Buenrostro, et al. 2012. Infiltrating cellular pattern in kidney graft biopsies translates into Foxp3 up-regulation and p16INK4α, senescence protein down-regulation in patients treated with belatacept compared to cyclosporine A. Clin. Exp. Immunol. 167:330337.
  • 12
    Muul, L. M., G. Heine, C. Silvin, S. P. James, F. Candotti, A. Radbruch, and M. Worm. 2011. Measurement of proliferative responses of cultured lymphocytes. Curr. Protoc. Immunol. 94:17. Chapter 7:Unit7.10.
  • 13
    US Renal Data System: USRDS. 2003. 2003 Annual data report; Atlas of end-stage renal diseases in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD.
  • 14
    Malat, G. E., K. M. Ranganna, N. Sikalas, L. Liu, R. M. Jindal, and A. Doyle. 2012. High frequency of rejections in HIV-positive recipients of kidney transplantation: a single center prospective trial. Transplantation 94:10201024.
  • 15
    Burns, J. M., B. C. Summers, Y. Wang, A. Melikian, R. Berahovich, Z. Miao, et al. 2006. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J. Exp. Med. 203:22012212.
  • 16
    Kuijpers, T. W., R. J. Bende, P. A. Baar, A. Grummels, I. A. Derks, K. M. Dolman, et al. 2010. CD20 deficiency in humans results in impaired T cell-independent antibody responses. J. Clin. Invest. 120:214222.
  • 17
    Newell, K. A., A. Asare, A. D. Kirk, T.D. Gisler, K. Bourcier, M. Suthanthiran, et al. 2010. Identification of a B cell signature associated with renal transplant tolerance in humans. J. Clin. Invest. 120:18361847.
  • 18
    Chong, A. S., and R. Sciammas. 2011. Matchmaking the B-cell signature of tolerance to regulatory B cells. Am. J. Transplant. 11:25552560.
  • 19
    Pallier, A., S. Hillion, R. Danger, M. Giral, M. Racapé, N. Degauque, et al. 2010. Patients with drug-free long-term graft function display increased numbers of peripheral B cells with a memory and inhibitory phenotype. Kidney Int. 78:503513.
  • 20
    Le Texier, L., P. Thebault, A. Lavault, C. Usal, E. Merieau, T. Quillard, et al. 2011. Long-term allograft tolerance is characterized by the accumulation of B cells exhibiting an inhibited profile. Am. J. Transplant. 11:429438.
  • 21
    Deeks, S. G., C. M. Kitchen, L. Liu, H. Guo, R. Gascon, A. B. Narváez, et al. 2004. Immune activation set point during early HIV infection predicts subsequent CD4+ T cell changes independent of viral load. Blood 104:942947.
  • 22
    Lederman, M., and L. Margolis. 2008. The lymph node in HIV pathogenesis. Semin. Immunol. 20:187195.
  • 23
    Presicce, P., K. Orsborn, E. King, J. Pratt, C. J. Fichtenbaum, and C. A. Chouqnet. 2011. Frequency of circulating regulatory T cells increases during chronic HIV infection and is largely controlled by highly active antiretroviral therapy. PLoS One 6:e28118.
  • 24
    VanBuskirk, A. M., W. J. Burlingham, E. Jankowska-Gan, T. Chin, S. Kusaka, F. Geissler, et al. 2000. Human allograft acceptance is associated with immune regulation. J. Clin. Invest. 106:145155.
  • 25
    Suchard, M. S., E. Mayne, V. A. Green, S. Shalekoff, S. L. Donninger, W.S. Stevens, et al. 2010. FOXP3 expression is upregulated in CD4+ T cells in progressive HIV-1 infection and is a marker of disease severity. PLoS One 5:e11762.